COVID-19 Regulatory Modification: Potential Gamechanger for the Healthcare Community?

With the onset of the COVID-19 Pandemic, the US government quickly moved to remove or curtail regulatory or administrative processes perceived as impeding healthcare delivery or receipt for clinicians and patients struggling with COVID-19. Regulatory changes from the Department of Health and Human Services (HHS) Office of Civil Rights, Office of Inspector General, and the Centers for Medicare & Medicaid Services (CMS) all figure prominently in the new healthcare delivery paradigm brought about by COVID-19. The changes are accelerating the use of digital health solutions and balancing the reimbursement field, all of which appear to be well received by the industry.

Join three prominent healthcare attorneys to discuss these issues in more depth. This session will provide a forum to learn what clinicians, developers, innovators, and patients are encountering at present; the evolution occurring across all healthcare stakeholders; and, how to prepare now for a future post-pandemic period.

Learning Objectives:

• Describe the breadth of regulatory and administrative changes in effect during the pandemic across the community and identify the key aspects driving such change
• Analyze the policy areas that need additional community-wide development and clarity as well as guidance from the government to advance national objectives
• Identify components of the temporary healthcare regulatory framework that should be considered for permanence and address critical policy gaps in the push to a post-pandemic healthcare delivery system

Other Speakers

Elaine C. Zacharakis, Attorey at Law with Zacharakis Loumbas Law LLC and Matthew R. Fisher, Partner, Mirick, O’Connell DeMallie & Lougee, LLP